Skip to main content
ELMD logo

ELMD · Electromed, Inc. · Webcasts, Transcripts & Audio

Track ELMD — free
$28.32 +0.22 (+0.78%) At close · Oct 5
Market Cap
$236.93M
Shares
8.37M
Volume · Oct 5 69.54K Avg daily vol (3M) 106.58K

Electromed, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Electromed, Inc. (ELMD), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-09-14
Electromed, Inc. (ELMD) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q4
2026-08-25
Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript
Confident tone Record financial performance Bronchiectasis market opportunity and awareness CEO succession
Revenue
$19.42M*
▲ 11.6% YoY
Gross margin
78.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-05-12
Electromed, Inc. (ELMD) Q3 2026 Earnings Call Transcript
Confident tone Bronchiectasis market opportunity Revenue and profit growth Clinical education and awareness campaigns
Revenue
$18.57M
▲ 18.4% YoY
Diluted EPS
$0.35
▲ 66.7% YoY
Gross margin
78.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-02-10
Electromed, Inc. (ELMD) Q2 2026 Earnings Call Transcript
Confident tone Bronchiectasis market opportunity Sales channel performance Capital allocation
Revenue
$18.90M
▲ 16.3% YoY
Diluted EPS
$0.32
▲ 45.5% YoY
Gross margin
78.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-11-12
Electromed, Inc. (ELMD) Q1 2026 Earnings Call Transcript
Confident tone Revenue and earnings growth Channel performance (home care, distributor, hospital) Bronchiectasis market opportunity
Revenue
$16.89M
▲ 15.1% YoY
Diluted EPS
$0.25
▲ 56.2% YoY
Gross margin
78.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-08-26
Electromed, Inc. (ELMD) Q4 2025 Earnings Call Transcript
Confident tone Revenue growth across all segments Bronchiectasis market opportunity Operational efficiency and technology
Revenue
$17.39M*
▲ 17.3% YoY
Gross margin
78.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-05-13
Electromed, Inc. (ELMD) Q3 2025 Earnings Call Transcript
Confident tone Revenue and earnings growth Bronchiectasis awareness and market development Sales force expansion
Revenue
$15.68M
▲ 13.1% YoY
Diluted EPS
$0.21
▲ 23.5% YoY
Gross margin
78.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-02-11
Electromed, Inc. (ELMD) Q2 2025 Earnings Call Transcript
Confident tone Record revenue and earnings performance Segment diversification Bronchiectasis awareness campaign
Revenue
$16.25M
▲ 18.7% YoY
Diluted EPS
$0.22
▲ 15.8% YoY
Gross margin
77.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-11-12
Electromed, Inc. (ELMD) Q1 2025 Earnings Call Transcript
Confident tone Revenue Growth SmartVest Clearway / Bronchiectasis Awareness Natural Disaster Risk Monitoring
Revenue
$14.67M
▲ 19% YoY
Diluted EPS
$0.16
▲ 700% YoY
Gross margin
78.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-08-27
Electromed, Inc. (ELMD) Q4 2024 Earnings Call Transcript
Confident tone Bronchiectasis market development SmartVest Clearway and product initiatives Insmed drug competitive landscape
Revenue
$14.83M*
▲ 9% YoY
Gross margin
76.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-05-07
Electromed, Inc. (ELMD) Q3 2024 Earnings Call Transcript
Confident tone Bronchiectasis market opportunity Change Healthcare cyberattack Revenue growth and record results
Revenue
$13.87M
▲ 14.9% YoY
Diluted EPS
$0.17
▲ 41.7% YoY
Gross margin
74.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-02-13
Electromed, Inc. (ELMD) Q2 2024 Earnings Call Transcript
Confident tone Market opportunity in bronchiectasis Hospital and distribution partnerships Sales force expansion
Revenue
$13.69M
▲ 16.7% YoY
Diluted EPS
$0.19
▲ 72.7% YoY
Gross margin
77.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-11-07
Electromed, Inc. (ELMD) Q1 2024 Earnings Call Transcript
Revenue
$12.32M
▲ 15.6% YoY
Diluted EPS
$0.02
▲ 100% YoY
Gross margin
77.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-08-22
Electromed, Inc. (ELMD) Q4 2023 Earnings Call Transcript
Revenue
$13.61M*
▲ 20.8% YoY
Gross margin
76.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-05-09
Electromed, Inc. (ELMD) Q3 2023 Earnings Call Transcript
Revenue
$12.07M
▲ 19% YoY
Diluted EPS
$0.12
▲ 71.4% YoY
Gross margin
75.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-02-14
Electromed, Inc. (ELMD) Q2 2023 Earnings Call Transcript
Revenue
$11.73M
▲ 14.5% YoY
Diluted EPS
$0.11
▲ 10% YoY
Gross margin
74.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-11-08
Electromed, Inc. (ELMD) Q1 2023 Earnings Call Transcript
Revenue
$10.66M
▲ 6.6% YoY
Diluted EPS
$0.01
▼ 80% YoY
Gross margin
78.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-08-23
Electromed, Inc. (ELMD) Q4 2022 Earnings Call Transcript
Revenue
$11.27M*
▲ 19% YoY
Gross margin
72.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-05-10
Electromed, Inc. (ELMD) Q3 2022 Earnings Call Transcript
Revenue
$10.14M
▲ 15.4% YoY
Diluted EPS
$0.07
▲ 133.3% YoY
Gross margin
76.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-02-08
Electromed, Inc. (ELMD) Q2 2022 Earnings Call Transcript
Revenue
$10.25M
▲ 7.9% YoY
Diluted EPS
$0.10
▼ 23.1% YoY
Gross margin
76.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-11-09
Electromed, Inc. (ELMD) Q1 2022 Earnings Call Transcript
Revenue
$10.00M
▲ 25% YoY
Diluted EPS
$0.05
▼ 16.7% YoY
Gross margin
77.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-08-09
Electromed, Inc. (ELMD) Q4 2021 Earnings Call Transcript
Revenue
$9.47M*
▲ 37.7% YoY
Gross margin
73.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-05-11
Electromed, Inc. (ELMD) Q3 2021 Earnings Call Transcript
Revenue
$8.79M
▲ 0.5% YoY
Diluted EPS
$0.03
▼ 57.1% YoY
Gross margin
76.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-02-09
Electromed, Inc. (ELMD) Q2 2021 Earnings Call Transcript
Revenue
$9.50M
▲ 11.1% YoY
Diluted EPS
$0.13
▼ 7.1% YoY
Gross margin
79.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-11-10
Electromed, Inc. (ELMD) Q1 2021 Earnings Call Transcript
Revenue
$8.00M
▼ 3.6% YoY
Diluted EPS
$0.06
▼ 50% YoY
Gross margin
76.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-08-25
Electromed, Inc. (ELMD) Q4 2020 Earnings Call Transcript
Revenue
$6.88M*
▼ 20.1% YoY
Gross margin
81.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-05-12
Electromed, Inc. (ELMD) Q3 2020 Earnings Call Transcript
Revenue
$8.74M
▲ 18% YoY
Diluted EPS
$0.07
▲ 75% YoY
Gross margin
75.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-02-11
Electromed, Inc. (ELMD) Q2 2020 Earnings Call Transcript
Revenue
$8.55M
▲ 6.7% YoY
Diluted EPS
$0.14
▲ 250% YoY
Gross margin
78.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2019-09-30
Electromed, Inc. (ELMD) Q1 2020 Earnings Call Transcript
Revenue
$8.30M
▲ 14.1% YoY
Diluted EPS
$0.12
▲ 500% YoY
Gross margin
76.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–29 of 29 webcasts
Key facts CIK 1488917 CUSIP 285409108 13F (30d) 5 filings 2 filers Visit website Investor relations